GenMark Diagnostics Total Assets 2010-2019 | GNMK

GenMark Diagnostics total assets from 2010 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
GenMark Diagnostics Annual Total Assets
(Millions of US $)
2019 $111
2018 $93
2017 $122
2016 $80
2015 $71
2014 $92
2013 $122
2012 $68
2011 $38
2010 $25
2009 $0
GenMark Diagnostics Quarterly Total Assets
(Millions of US $)
2019-12-31 $111
2019-09-30 $85
2019-06-30 $87
2019-03-31 $97
2018-12-31 $93
2018-09-30 $91
2018-06-30 $98
2018-03-31 $111
2017-12-31 $122
2017-09-30 $129
2017-06-30 $146
2017-03-31 $64
2016-12-31 $80
2016-09-30 $86
2016-06-30 $63
2016-03-31 $61
2015-12-31 $71
2015-09-30 $77
2015-06-30 $84
2015-03-31 $92
2014-12-31 $92
2014-09-30 $98
2014-06-30 $107
2014-03-31 $114
2013-12-31 $122
2013-09-30 $129
2013-06-30 $57
2013-03-31 $64
2012-12-31 $68
2012-09-30 $69
2012-06-30 $74
2012-03-31 $32
2011-12-31 $38
2011-09-30 $44
2011-06-30 $51
2011-03-31 $22
2010-12-31 $25
2010-09-30 $28
2010-06-30 $33
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.253B $0.088B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.415B 22.23
Intuitive Surgical (ISRG) United States $57.255B 42.46
Edwards Lifesciences (EW) United States $41.438B 35.58
DexCom (DXCM) United States $24.086B 143.69
ALCON INC (ALC) Switzerland $22.911B 0.00
IDEXX Laboratories (IDXX) United States $19.775B 47.49
Fresenius Medical Care AG KGaA (FMS) Germany $19.189B 12.71
Olympus (OCPNY) Japan $18.956B 0.00
Sysmex ADR (SSMXY) Japan $15.069B 42.47
Teleflex (TFX) United States $13.098B 25.34
SONOVA HOLDING (SONVY) Switzerland $11.637B 0.00
STERIS (STE) Ireland $11.004B 23.46
Masimo (MASI) United States $9.549B 55.60
Varian Medical Systems (VAR) United States $9.155B 21.30
Hologic (HOLX) United States $8.757B 13.47
SARTORIUS AG (SARTF) Germany $7.545B 67.04
ABIOMED (ABMD) United States $6.545B 34.50
Penumbra (PEN) United States $5.446B 160.18
Globus Medical (GMED) United States $4.151B 24.60
Tandem Diabetes Care (TNDM) United States $4.086B 0.00
Wright Medical Group (WMGI) Netherlands $3.733B 414.29
Integra LifeSciences Holdings (IART) United States $3.525B 15.24
Nihon Kohden (NHNKY) Japan $3.203B 32.23
Elekta AB (EKTAY) Sweden $2.991B 23.03
Nevro (NVRO) United States $2.864B 0.00
LivaNova (LIVN) United Kingdom $2.111B 15.40
Integer Holdings (ITGR) United States $1.880B 12.25
Glaukos (GKOS) United States $1.458B 0.00
Cantel Medical (CMD) United States $1.404B 13.52
Luminex (LMNX) United States $1.215B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.197B 23.42
Veracyte (VCYT) United States $1.152B 0.00
Inogen (INGN) United States $1.103B 46.78
ShockWave Medical (SWAV) United States $1.039B 0.00
Silk Road Medical (SILK) United States $0.970B 0.00
OPKO Health (OPK) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.900B 47.13
Natus Medical (NTUS) United States $0.750B 17.60
Tactile Systems Technology (TCMD) United States $0.748B 69.55
OrthoPediatrics (KIDS) United States $0.612B 0.00
CryoLife (CRY) United States $0.607B 50.06
Pacific Biosciences Of California (PACB) United States $0.502B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.498B 17.65
Accelerate Diagnostics (AXDX) United States $0.439B 0.00
Intersect ENT (XENT) United States $0.396B 0.00
AxoGen (AXGN) United States $0.371B 0.00
AngioDynamics (ANGO) United States $0.350B 16.03
Si-Bone (SIBN) United States $0.322B 0.00
ViewRay (VRAY) United States $0.311B 0.00
Quotient (QTNT) Switzerland $0.277B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.260B 0.00
TransMedics (TMDX) United States $0.250B 0.00
Alphatec Holdings (ATEC) United States $0.238B 0.00
IRadimed (IRMD) United States $0.223B 25.23
SeaSpine Holdings (SPNE) United States $0.219B 0.00
Semler Scientific (SMLR) United States $0.213B 25.42
Fluidigm (FLDM) United States $0.175B 0.00
Accuray (ARAY) United States $0.151B 0.00
RTI Surgical (RTIX) United States $0.139B 37.60
Sientra (SIEN) United States $0.111B 0.00
Restoration Robotics (VERO) Canada $0.108B 0.00
Vermillion (VRML) United States $0.088B 0.00
Spectral Diagnostics (EDTXF) Canada $0.078B 0.00
Allied Healthcare Products (AHPI) United States $0.069B 0.00
EDAP TMS S.A (EDAP) France $0.068B 17.92
MRI Interventions (CLPT) United States $0.056B 0.00
ConforMIS (CFMS) United States $0.049B 0.00
Apollo Endosurgery (APEN) United States $0.043B 0.00
Sensus Healthcare (SRTS) United States $0.039B 0.00
Second Sight Medical Products (EYES) United States $0.037B 0.00
T2 Biosystems (TTOO) United States $0.030B 0.00
Neuronetics (STIM) United States $0.030B 0.00
Bioanalytical Systems (BASI) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Ra Medical Systems (RMED) United States $0.015B 0.00
Sunshine Heart Inc (CHFS) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Helius Medical Technologies (HSDT) United States $0.009B 0.00
Avinger (AVGR) United States $0.008B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Viveve Medical (VIVE) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
ReWalk Robotics (RWLK) Israel $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00